Return to content in this issue
Changes in Thymus and Activation-Regulated Chemokine in Patients With Type 2 Inflammatory Disease Receiving Dupilumab
Zhou B, Liang S, Shang S, Xiang L, Li L
Department of Dermatology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
J Investig Allergol Clin Immunol 2023; Vol 33(1)
: 74-75
doi: 10.18176/jiaci.0874
Key words: Thymus and activation-regulated chemokine, Type 2 inflammatory disease, Atopic dermatitis, Dupilumab
| Title | Type | Size | |
|---|---|---|---|
 |
doi10.18176_jiaci.0874_supplemental-materials-fig.pdf | 3.10 Mb | |
|
doi10.18176_jiaci.0874_supplemental-materials-tables_1.pdf | 184.21 Kb |
